🎁 Black Friday: up to 50% off of annual plans
Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
4.560
-0.270 (-5.59%)
At close: Nov 20, 2026, 4:00 PM EST
4.749
+0.189 (4.15%)
After-hours: Nov 20, 2026, 7:30 PM EST

Strata Critical Medical Statistics

Total Valuation

SRTA has a market cap or net worth of $407.30 million. The enterprise value is $369.28 million.

Market Cap407.30M
Enterprise Value 369.28M

Important Dates

The last earnings date was Tuesday, November 3, 2026, before market open.

Earnings Date Nov 3, 2026
Ex-Dividend Date n/a

Share Statistics

SRTA has 89.32 million shares outstanding. The number of shares has increased by 6.93% in one year.

Current Share Class 89.32M
Shares Outstanding 89.32M
Shares Change (YoY) +6.93%
Shares Change (QoQ) +2.39%
Owned by Insiders (%) 14.14%
Owned by Institutions (%) 52.34%
Float 59.17M

Valuation Ratios

PE Ratio n/a
Forward PE 79.30
PS Ratio 1.45
Forward PS 1.28
PB Ratio 1.47
P/TBV Ratio 3.52
P/FCF Ratio 505.33
P/OCF Ratio 37.98
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 42.06, with an EV/FCF ratio of 458.16.

EV / Earnings n/a
EV / Sales 1.32
EV / EBITDA 42.06
EV / EBIT n/a
EV / FCF 458.16

Financial Position

The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.01.

Current Ratio 2.77
Quick Ratio 1.87
Debt / Equity 0.01
Debt / EBITDA 0.36
Debt / FCF 4.50
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -7.55% and return on invested capital (ROIC) is -2.89%.

Return on Equity (ROE) -7.55%
Return on Assets (ROA) -7.47%
Return on Invested Capital (ROIC) -2.89%
Return on Capital Employed (ROCE) -4.62%
Weighted Average Cost of Capital (WACC) 18.17%
Revenue Per Employee $858,587
Profits Per Employee -$75,872
Employee Count327
Asset Turnover 0.85
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +8.06% in the last 52 weeks. The beta is 2.56, so SRTA's price volatility has been higher than the market average.

Beta (5Y) 2.56
52-Week Price Change +8.06%
50-Day Moving Average 5.00
200-Day Moving Average 5.11
Relative Strength Index (RSI) 38.32
Average Volume (20 Days) 1,319,706

Short Selling Information

The latest short interest is 4.55 million, so 5.09% of the outstanding shares have been sold short.

Short Interest 4.55M
Short Previous Month 4.54M
Short % of Shares Out 5.09%
Short % of Float 7.69%
Short Ratio (days to cover) 4.98

Income Statement

In the last 12 months, SRTA had revenue of $280.76 million and -$24.81 million in losses. Loss per share was -$0.29.

Revenue280.76M
Gross Profit 60.56M
Operating Income -13.12M
Pretax Income -21.12M
Net Income -24.81M
EBITDA 8.78M
EBIT -13.12M
Loss Per Share -$0.29
Full Income Statement

Balance Sheet

The company has $41.64 million in cash and $3.62 million in debt, with a net cash position of $38.02 million or $0.43 per share.

Cash & Cash Equivalents 41.64M
Total Debt 3.62M
Net Cash 38.02M
Net Cash Per Share $0.43
Equity (Book Value) 276.38M
Book Value Per Share 3.09
Working Capital 80.02M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $10.72 million and capital expenditures -$9.92 million, giving a free cash flow of $806,000.

Operating Cash Flow 10.72M
Capital Expenditures -9.92M
Depreciation & Amortization 21.90M
Net Borrowing n/a
Free Cash Flow 806,000
FCF Per Share $0.01
Full Cash Flow Statement

Margins

Gross margin is 21.57%, with operating and profit margins of -4.67% and -8.84%.

Gross Margin 21.57%
Operating Margin -4.67%
Pretax Margin -7.52%
Profit Margin -8.84%
EBITDA Margin 3.13%
EBIT Margin -4.67%
FCF Margin 0.29%

Dividends & Yields

SRTA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -6.93%
Shareholder Yield -6.93%
Earnings Yield -6.32%
FCF Yield 0.20%

Analyst Forecast

The average price target for SRTA is $9.63, which is 111.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.63
Price Target Difference 111.08%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (3Y) 17.28%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

SRTA has an Altman Z-Score of 5.37 and a Piotroski F-Score of 4.

Altman Z-Score 5.37
Piotroski F-Score 4